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“Guaraná” (Paullinia cupana) is used as a physical activity enhancer and stimulator due to its 
methylxanthines and condensed tannins. The aim of this work was to evaluate the dissolution behavior 
of five herbal medicines in the form of capsules and tablets containing guaraná. Assay and dissolution 
methods were validated and results obtained allowed simultaneous marker quantification with precision, 
accuracy, selectivity and robustness. Findings showed that 100% of the herbal medicinal products 
analyzed did not provide satisfactory results concerning the presence of four markers, 60% had three 
markers (caffeine, catechin and epicatechin), while 40% had only caffeine at tested dosage forms. 
In addition, after 30 minutes, only capsule A showed at least 80% of the dissolved markers. In other 
capsules, marker dissolution did not exceed 60% whereas 60% of the samples had some characteristic 
pharmacotechnical problems. These results evidence the need for rigorous quality control to help ensure 
the therapeutic action of these drugs. To this end, dissolution studies are an essential tool for quality 
assurance of herbal medicines.
Uniterms: Herbal medicines/quality control. Herbal medicines/dissolution behavior. Medicinal plants. 
Guaraná/pharmacognosy. Paullinia cupana/pharmacognosy.
Guaraná (Paullinia cupana) é utilizado como revigorante e estimulante devido à presença de metilxantinas 
e taninos condensados. Este trabalho visou avaliar o comportamento de dissolução de cinco fitoterápicos, 
na forma de cápsulas e comprimidos, contendo guaraná. O método de quantificação e de dissolução 
foram validados e os resultados obtidos permitiram a quantificação dos marcadores simultaneamente, 
com precisão, exatidão, seletividade e robustez. Foi verificado que 100% dos fitoterápicos analisados 
encontravam em desacordo quanto à presença dos quatro marcadores, sendo que 60% apresentaram três 
marcadores (cafeína, catequina e epicatequina) e 40% apresentaram somente a cafeína. Além disso, após 
o tempo de 30 minutos de ensaio foi possível observar que somente a cápsula A apresentou pelo menos 
80% dos marcadores dissolvidos. Nas demais cápsulas o comportamento de dissolução apresentado 
pelos marcadores não ultrapassou 60% e, além disso, 60% das amostras apresentaram alguns problemas 
farmacotécnicos característicos. Frente aos resultados obtidos torna-se evidente a necessidade de um 
rigoroso controle de qualidade que contribua para assegurar a ação terapêutica desses medicamentos e, 
nesse sentido, o estudo de dissolução constitui uma ferramenta essencial para a garantia de qualidade 
dos fitoterápicos.
Unitermos: Fitoterápicos/controle de qualidade. Fitoterápicos/comportamento de dissolução. Plantas 
medicinais. Guaraná/farmacognosia. Paullinia cupana/farmacognosia.
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INTRODUCTION
Paullinia cupana Kunth. (“Guaraná”) is a plant of 
the Sapindaceae family, native to the Brazilian Amazon. 
Dried and slightly toasted seeds are the most commonly 
used parts (Rates, 2002). This plant is widely employed in 
Brazilian traditional medicine, has been used in industrial 
and homemade drinks as stimulating tonics and in cosme-
tic preparations. Moreover, the plant is indicated in cases 
of exhaustion, nervous depression and migraine treatment 
(Moraes, Micke, Tavares, 2003).
The seeds of “guaraná” are characterized by the pre-
sence of methylxanthines, mainly caffeine and theophylli-
ne plus theobromine in smaller quantities, as well as con-
densed tannins such as catechin, epicatechin, procyanidin 
B2, procyanidin B3 and procyanidin B4, which are dimeric 
units composed of flavan-3-ol (Antonelli-Ushirobira et al., 
2007). The stimulating property attributed to “guaraná” is 
mostly due to the presence of caffeine, while the tannins 
are responsible for its astringent flavor. Some studies have 
demonstrated its antioxidant, antiviral, antibacterial and 
slimicide activities, besides some enzymatic inhibition 
(Yamaguti-Sasaki et al., 2007).
For a herbal medicinal product to be safe and effec-
tive, among other factors, it requires rigorous quality 
control. In the case of solid oral dosage forms, certain 
parameters should be evaluated that involve an assessment 
of the dosage form, since some conditions and manufac-
turing processes may limit drug release and therefore 
its absorption, compromising pharmacological activity 
(Ansel, Popovich, Allen, 2000).
Due to their importance, dissolution tests are fre-
quently used for synthetic drug quality control, but their 
use in natural product evaluation has not been widely 
adopted (Taglioli et al., 2001), which is a problem (Bem-
pong, Houghton, 1992; Taglioli et al., 2001; Kressmann 
et al., 2002; Westerhoff et al., 2002; Sittichai et al., 2007; 
Kratz et al., 2008). A peculiarity of herbal medicines is 
the fact that in many cases the in vivo/in vitro biophar-
maceutical characterization is hard due to their complex 
composition, high metabolism suffered by constituents 
in the plants itself, and because of the different, often 
difficult, methods for extraction involved (Emea, 2003), 
as well as for quantification of analytes in phytocomplex 
(Williamson, 2001).
In the present work, methods were developed and 
validated for both liquid chromatography as well as dis-
solution in order to evaluate the dissolution behavior of 
capsules and tablets of “guaraná” purchased from the local 
market, using the release of theophylline, caffeine, cate-
chin and epicatechin, quantified by HPLC, as a parameter.
MATERIALS AND METHODS
Samples
The samples used were three brands of capsules and 
two of tablets containing “guaraná” randomly purchased 
from local shops (Goiânia-GO, Brazil). 
The HPLC profile of an authentic sample of “gua-
raná” (dried fruit) identified by Prof Dr José Realino de 
Paula - FF/UFG, was performed to establish a specification 
for the analysis of the herbal medicines sold.
Quantification of markers of “guaraná” by HPLC
The method used for determination of methylxan-
thines (caffeine and theophylline) and tannins was based 
on that proposed by Saito et al. (2006), employed for the 
determination of epigallocatechin, epicatechin, catechin 
and caffeine in green tea samples.
A Varian® (Palo Alto, California, USA) liquid chro-
matograph Pro Star model equipped with a model Pro Star 
410 automatic injection system, Pro Star 240 quaternary 
pump and model Pro Star 310 – UV-Visible detector, were 
used.
Chromatographic conditions were the following: 
RP 18, 250 x 4.6 mm, 5 µm (Varian) chromatographic 
column at isocratic elution mode, wavelength at 274 nm, 
injection volume of 20 µL (performed in duplicate), mo-
bile phase flow of 1mL/min and mobile phase consisting 
of Water: Acetonitrile: Methanol: Ethyl acetate: Acetic 
acid (89: 6: 1: 3: 1). The standards used were caffeine 
anhydrous (99%), catechin hydrate (96%), epicatechin 
(90%) and teophylline anhydrous (99%), purchased from 
Sigma Aldrich.
To perform caffeine, theophylline, catechin and 
epicatechin assay, samples were prepared according to 
the Farmacopeia Brasileira (2003), except for the different 
solvent used for determination of methylxanthines (solu-
tion of hydrochloric acid 0.1 M). To prepare samples, the 
average weight of capsules and tablets was first determined 
according to the Farmacopeia Brasileira (1988). For the 
quantification of the markers, the equivalent of 250 mg of 
herbal content was weighed and transferred to a 100 mL 
volumetric flask. After being subjected to a mechanical 
horizontal shaker for 15 min with four portions of 20 mL of 
0.1 M hydrochloric acid for extraction of methylxanthines 
and tannins, the volume of the flask was supplemented 
with 0.1 M hydrochloric acid. The sample was filtered 
using filter paper and injection was performed in duplicate 
for chromatography.
The calculation of the content of caffeine, theo-
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phylline, catechin and epicatechin was performed using 
the following formula:
In which: SA = sample area; SA’ = standard area; 
SC = standard concentration (mg/mL); DF = dilution 
factor; W = sample weight in mg.
Chromatographic method validation
The validation of the analytical method for quantifi-
cation of theophylline, caffeine, catechin and epicatechin 
in “guaraná” by HPLC was performed according to RE 
No. 899/2003 ANVISA (Brazil, 2003). The parameters 
evaluated were selectivity, linearity and range, precision 
(repeatability and intermediate), accuracy and robustness.
Selectivity was determined by analyzing the chro-
matographic profile (retention time and resolution) of the 
samples (capsules and tablets), standard compounds and 
solvent, HCl 0.1 M (blank) in order to verify possible 
interference.
 The linearity was determined for each marker by in-
jecting six different concentrations of the standard mixture 
into the HPLC apparatus. The solutions of the standards 
(theophylline, caffeine, catechin and epicatechin) were 
prepared in methanol, followed by serial dilution to achie-
ve concentrations ranging from 0.5 μg/mL to 15.0 μg/mL. 
Precision (repeatability) was determined by prepa-
ring and analyzing six replicates of the sample at 100% 
concentration. For this procedure, samples were prepared 
accordingly to the method described above. The results 
were expressed as relative standard deviation (RSD%).
Precision (intermediate) was determined by 
analyzing the sample in triplicate at 100% on two days 
and by two different analysts. For this procedure, samples 
were prepared accordingly to the method described abo-
ve. The results were again expressed as relative standard 
deviation (RSD%). 
Accuracy determination was undertaken by 
analyzing the sample in triplicate at the concentrations 
of 50, 100 and 150%, and was verified by the recovery 
procedure, i.e. verification of the differences between the 
averages of these values and the theoretical value found.
The robustness of the method was evaluated in tri-
plicate using the following parameters: wavelength of the 
reading at 272 nm, 274 nm and 276 nm, and flow of the 
mobile phase at 0.8 mL/min, 1.0 mL/min and 1.2 mL/min. 
The result was expressed as relative standard deviation 
(RSD%).
Dissolution test
The analytical methodology used to evaluate dis-
solution followed United States Pharmacopeia (2007) 
specifications, which describe the general methodology 
for capsule and tablet dissolution tests. Tests were carried 
out on a Vankel VK 7000 Total Solution Dissolution device 
using USP apparatus 2 (paddle), HCl 0.1 M pH 1.2 me-
dium, dissolution vessel volume of 900 mL, 37.5 ± 0.5 ºC 
temperature, stirring speed of 75 rpm, and sampling 
aliquots of 3 mL withdrawn at 0, 5, 10 and 30 minutes. 
Samples were automatically collected, filtrated and as-
sayed by HPLC.
Validation of dissolution method
The dissolution test is classified according to its 
purpose in test category III, hence the need for validation 
assessment of the precision parameter by means of repe-
atability (Brazil, 2003).
The precision evaluated at the repeatability level 
was determined by analysis of six individual samples (six 
replicates) collected from dissolutor at a time of 30 minu-
tes. The repeatability was expressed as relative standard 
deviation between samples (RSD%).
RESULTS AND DISCUSSION
Validation of HPLC method for quantification of 
markers for P. cupana
The selection of the wavelength of 274 nm was 
made by assessing the absorption spectra in the UV range 
of methylxanthines (theophylline and caffeine), catechin 
and epicatechin.
The choice of mobile phase pH was based on the 
pKa of the substances being eluted. The pKa of methylxan-
thines can vary from 8.4 to 13.9 and of catechins from 
8.6 to 13.2 (Gennaro, 2004). The pH of the mobile phase 
must be below the ionization constant, because the incre-
ased ionized analyte raises its dissolution in the aqueous 
phase and reduces its retention time, since the ionic form 
passes through the column without retention (Ivanovic et 
al., 1995).
 The HPLC method used was linear, selective, pre-
cise, accurate and robust for the four markers present in 
the “guaraná”, namely, theophylline, caffeine, catechin 
and epicatechin.
The method of identification and quantification of 
methylxanthines, catechin and epicatechin by high perfor-
mance liquid chromatography was selective because it is 
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capable of separating the markers, as shown in Figure 1. The 
data shows that the solution used for dilution of the markers 
does not interfere with the peak of the markers in the sample.
For the markers quantified, the method was linear 
with a value of r2 = 0.9992 for theophylline (y = 0.36074x 
+ 1.11898), 0.9979 for caffeine (y = 0.37758x + 0), 0.9982 
for catechin (y = 0.08182x + 0), and 0.9990 for epicatechin 
(y = 0.07145x + 0).
The method was shown to be precise for quantifi-
cation of the four markers, in both repeatability and inter-
mediate precision, with RDS < 5% (Table I).
The method was shown to be accurate for theo-
phylline, caffeine, catechin and epicatechin, with recovery 
values ranging from 95.18% to 104.11%.
The method was robust since it resisted slight wa-
velength variations (272, 274 and 276 nm); and mobile 
phase flow variations – 0.8; 1.0 and 1.2 mL/min for the 
theophylline, caffeine, catechin and epicatechin evaluated. 
RSD values were less than 5%.
Quantification of markers of P. cupana
A large variation in the percentage of the caffeine 
marker (1.32 to 6.51%) was observed among the five herbal 
samples analyzed, which was not related to the catechin and 
epicatechin (Table II, Figure 2). Given the stimulant acti-
vity of “guaraná” is mainly due to the presence of caffeine 
(Yamaguti-Sasaki et al., 2007), the non-uniformity in the 
TABLE I - Precision of HPLC method for quantification of markers of P. cupana
Repeatability
Marker Mean Concentration/ RSD (µg/mL) Mean %
Theophylline 0.2599 / 4.46 0.1039
Caffeine 14.55 / 1.74 5.82
Catechin 2.04 / 3.17 0.82
Epicatechin 1.84 / 4.01 0.73
Intermediate precision
Theophylline 0.2297 /3.61 0.0919
Caffeine 14.70 / 1.85 5.88
Catechin 2.01 / 2.80 0.80
Epicatechin 1.91 / 4.16 0.77
FIGURE 1 - Theophylline, caffeine, catechin and epicatechin standard solution chromatogram. Chromatographic conditions: water, 
acetonitrile, methanol, ethyl acetate and acetic acid (89:6:1:3:1) mobile phase; isocratic elution; flow of 1 mL/min; Varian® RP 18 
250 x 4.6 mm, 5 µm column; and detector at 274 nm.
Dissolution test of herbal medicines containing Paullinia cupana 273
TABLE II - Percentage of markers in capsules and tablets of P. cupana analyzed
Samples Markers
Caffeine Theophylline Catechin Epicatechin
Capsule A 2.37 % 0.0 0.49% 0.49%
Capsule B 3.36% 0.0 0.60% 0.68%
Capsule C 6.51% 0.0 0.0 0.0
Tablet A 2.64% 0.0 0.0 0.0
Tablet B 1.32% 0.0 0.34% 0.41%
FIGURE 2 - Herbal medicine chromatogram. Chromatographic conditions: water, acetonitrile, methanol, ethyl acetate and acetic 
acid (89:6:1:3:1) mobile phase; isocratic elution; flow of 1 mL/min; Varian® RP 18 250 x 4.6 mm, 5 µm column; and detector at 
274 nm. A- Capsule A, B - Capsule B, C- Capsule C, D – Tablet A, E – Tablet B.
concentration of this drug reveals a problem in relation to 
the dosage used and efficiency of this herbal medicine.
Thus, it is noteworthy that one of the great challen-
ges faced by the botanical drugs market is the standardi-
zation of biological materials from natural sources. New 
technologies to modernize traditional herbs into mainstre-
am pharmaceutical products are being evaluated with the 
goal of maximizing the opportunities and overcoming the 
challenges (Liu, Wang, 2008).
Validation of dissolution method:
The method was shown to be precise for the quan-
tification of four markers, in repeatability precision, with 
aliquots being removed at the 30-minute timepoint, and 
RDS < 5%. For theophylline, the percentage was 0.0986, 
SD 0.0023 with RSD of 2.37. For caffeine, the percen-
tage was 6.22, SD 0.08 and RSD 1.38. For catechin, the 
percentage was 0.88, SD 0.02 and RSD 3.04. Finally, 
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for epicatechin, the percentage was 0.72, SD 0.03 and 
RSD 4.39.
Dissolution test
None of the five samples of herbal medicines 
analyzed showed satisfactory results regarding dissolution 
profile and presence of the four proposed markers (Table 
III, Figure 3).
After 30 minutes, capsule A presented at least 80% 
of the markers dissolved (Figure 3A). In the other cap-
sules, the dissolution profile presented by the markers, 
when present, did not exceed 60% (Figures 3B and C), 
probably due to formulation problems such as excipients 
and handling process used. Among the tablets, sample A 
reached 100% dissolution for caffeine, and was the only 
marker detected (Figure 3D). In tablet B, possibly due to 
pharmacotechnical problems, e.g. strength compression, 
its total disintegration, and consequently its total disso-
lution, did not occur, not releasing more than 40% of the 
markers assayed (Figure 3E).
The drug manufacturing processes and formulation 
components involved can influence dissolution and bioa-
vailability. Tablets obtained by direct compression, dry or 
wet granulation, may display different in vitro and in vivo 
behavior. These factors directly affect dosage form disag-
gregation in gastrointestinal fluids, influencing dissolution 
and consequently, drug absorption (Storpirtis et al., 1999).
The results of this study also demonstrated that 
among the samples, 60% had three markers present 
(caffeine, catechin and epicatechin) (Figures 3A, B and 
E) while 40% had only caffeine as a marker (Figures 3C 
and D). Since catechin, epicatechin and theophylline are 
markers of P. cupana (Farmacopeia Brasileira, 2003; 
Antonelli-Ushirobira et al., 2007) its absence in some 
samples point to a quality problem. Furthermore, only the 
presence of caffeine in some herbal medicines analyzed 
is an important non-compliance. This result suggests 
the poor quality of these herbal medicines and possible 
adulteration by sophistication practices, for example, the 
addition of synthetic caffeine P. cupana powder. Sophisti-
cations practices are difficult to detect and occur usually by 
addition of synthetic or natural substances with structures 
similar to those of the active principle, medicinal plants 
or herbal products with low quantity of active principle, 
in order to fool quality control (Sharapin, 2000; Rocha, 
2009). Moreover, for quality assurance purposes, desirable 
attributes include authenticity and purity. Authenticity 
relates to proving that the material is genuine and involves 
parameters including chemical analysis. Purity pertains to 
evaluating that there are no adulterants present in the plant 
material (Yadav, Dixit, 2008).
Another important aspect to highlight is that consi-
dering solid oral medicines can present major problems 
in relation to bioavailability, it is important to evaluate 
the dissolution of the drug from the dosage form by per-
TABLE III - Percentage of dissolution versus time for herbal medicines tested
% Dissolution (mean)
time theophylline (± SD) caffeine (± SD) catechin (± SD) epicatechin (± SD)
Capsule A 5’ 0.00 41.50 (± 1.95) 34.90 (± 0.47) 42.71 (± 0.51)
10’ 0.00 70.05 (± 1.76) 56.64 (± 0.35) 69.60 (± 0.40)
30’ 0.00 102.25 (± 2.07) 79.59 (± 0.51) 101.31 (± 0.48)
Capsule B 5’ 0.00 19.60 (± 1.25) 15.17 (± 0.18) 21.50 (± 0.31)
10’ 0.00 34.92 (± 2.27) 26.72 (± 0.28) 37.37 (± 0.48)
30’ 0.00 59.88 (± 1.82) 42.90 (± 0.31) 55.84 (± 0.37)
Capsule C 5’ 0.00 0.05 (± 0.01) 0.00 0.00
10’ 0.00 0.97 (± 0.07) 0.00 0.00
30’ 0.00 18.28 (± 4.44) 0.00 0.00
Tablet A 5’ 0.00 59.86 (± 0.82) 0.00 0.00
10’ 0.00 99.96 (± 0.33) 0.00 0.00
30’ 0.00 106.49 (± 0.29) 0.00 0.00
Tablet B 5’ 0.00 6.98 (± 0.15) 2.91 (± 0.03) 5.62 (± 0.11)
10’ 0.00 12.95 (± 0.15) 8.82 (± 0.08) 10.84 (± 0.05)
30’ 0.00 39.93 (± 0.47) 33.02 (± 0.13) 34.43 (± 0.17)
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FIGURE 3 - Dissolution profile of herbal medicines of P. cupana, using apparatus 2 (paddle), HCl 0.1 M pH 1.2 medium, dissolution 
vessel volume of 900 mL, 37.5 ± 0.5 ºC temperature, stirring speed of 75 rpm, at 0, 5, 10 and 30 minutes. A- Capsule A, B - Capsule 
B, C- Capsule C, D – Tablet A, E – Tablet B.
forming in vitro tests that help to visualize the dissolution 
profile as a function of time.
Literature has demonstrated concerning data rela-
ted to herbal medicinal product dissolution tests. A study 
performed with phytomedicines based on Ginkgo biloba 
demonstrated that 85% of the evaluated products failed to 
have the recommended chemical composition and there-
fore their use could not be indicated (Kratz et al., 2008). 
In another study on Ginkgo biloba extract capsules and 
tablets, marked differences in dissolution behavior were 
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found, with values of 99% and 33% dissolution, on avera-
ge, after 15 minutes and 1 hour, respectively (Kressmann 
et al., 2002). The dissolution profile of Senna sp was less 
than 10% sennoside release from capsules containing dry 
extract, in a period of 60 minutes, in contrast to lyophilized 
Senna sp extract, which attained around 90% dissolution 
after the same period. Data on the dissolution test of Passi-
flora sp showed that capsules containing the crude extract 
presented 50% dissolution while lyophilized extract and 
other standardized extract reached around 100% for the 
same period (Taglioli et al., 2001).
Considering the increasing consumption of herbal 
medicines, P. cupana included, there is a need for studies 
to ensure quality from raw material to finished product. 
Quality control is essential for the efficacy and safety of 
herbal products. Thus, dissolution studies are of great 
importance since they can contribute toward ensuring the 
effectiveness of herbal medicines.
CONCLUSION
The results showed that the quality of herbal me-
dicines containing “guaraná” represents a serious public 
health problem, since 100% of the samples analyzed 
differed in terms of the presence of chemical markers of 
the drug both on the dissolution test as well as in relation 
to pharmacotechnical aspects.
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